PIK3C2A and diabetes mellitus: Blood component testing suggested that BH4 treatment did not affect glucose (fasting glucose and intraperitoneal glucose tolerance test (IPGTT)) and fat metabolism (LDL, TC, and TG) in the body but rather prevented heart damage (CPK and LDH) caused by diabetes (Table 1 and Fig S1).